key: cord-0804086-flcxvov3 authors: Pons-Salort, M.; John, J.; Watson, O. J.; Brazeau, N. F.; Verity, R.; Kang, G.; Grassly, N. C. title: Reconstructing the COVID-19 epidemic in Delhi, India: infection attack rate and reporting of deaths date: 2021-03-26 journal: nan DOI: 10.1101/2021.03.23.21254092 sha: ea6174d8d5d70e48a2558f3b7ba66a248ba2aaa6 doc_id: 804086 cord_uid: flcxvov3 India reported over 10 million COVID-19 cases and 149,000 deaths in 2020. To estimate exposure and the potential for further spread, we used a SARS-CoV-2 transmission model fit to seroprevalence data from three serosurveys in Delhi and the time-series of reported deaths to reconstruct the epidemic. The cumulative proportion of the population estimated infected was 48.7% (95% CrI 22.1% - 76.8%) by end-September 2020. Using an age-adjusted overall infection fatality ratio (IFR) based on age-specific estimates from mostly high-income countries (HICs), we estimate that 15.0% (95% CrI 9.3% - 34.0%) of COVID-19 deaths were reported. This indicates either under-reporting of COVID-19 deaths and/or a lower age-specific IFR in India compared with HICs. Despite the high attack rate of SARS-CoV-2, a third wave occurred in late 2020, suggesting that herd immunity was not yet reached. Future dynamics will strongly depend on the duration of immunity and protection against new variants. reporting and estimate the infection attack rate in one of India's largest metropolitan areas, home to 20 million people. SARS-CoV-2 transmission in Delhi has led to three waves of infection and mortality (Figure 1 ). At the beginning of the epidemic, all SARS-CoV-2 testing relied on RT-PCR, but since mid-June, antigen-based rapid diagnostic tests (Ag-RDTs), which have a lower sensitivity, have also been used and quickly exceeded the daily number of RT-PCR tests ( Figure S1 ). Three serosurveys were conducted in Delhi in July, August and September, sampling individuals over 4 years old, found an age-and sex-adjusted seropositivity rate (uncorrected for test sensitivity and specificity) of 22.8%, 28.7% and 25 .1% respectively (details in Table S1 ) 3 . Although the first serosurvey found a difference between slum and non-slum areas (25.3% vs. 19 .2%, p<0.001), the second did not (28.9% vs. 28 .8%, p=0.94), and the third did not report this information. We developed a SARS-CoV-2 transmission model to estimate the incidence of infection and changes in the reproduction number (R) following implementation of non-pharmaceutical interventions, including lockdowns (Table S2, Figure S2 ). We used Bayesian Markov Chain Monte Carlo to fit the model to the three seroprevalence surveys and the time-series of reported deaths. The proportion of COVID-19 deaths reported was estimated by comparing reported deaths to those expected based on the age-adjusted IFR. We used estimates of the age-specific IFR based on data from 7 European countries, New York (USA) and Brazil 4 , to give a median age-adjusted IFR for Delhi of 0.39% (95% prediction interval 0.21 -0.85%; this compares with ~1% in high-income countries with older populations such as the UK 5,6 ). Agespecific estimates from early data from China 6 and from a meta-analysis in "advanced economies" 7 gave a very similar value (0.39% and 0.40%, respectively). See the Online Methods for more details of the modelling and inference framework. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint This may be because the observation model does not account for waning antibodies and the possibility of seroreversion. However, the third serosurvey used a different testing kit, which could also contribute to this difference. We estimate that the first peak in incidence of (95% CrI 22.1% -76.8%) by the end of September. Since then, Delhi has experienced a large third wave of cases and deaths (Figure 1 ), therefore suggesting that even with half of the population having been infected, the herd immunity threshold was not yet reached at that time. Interestingly, a serosurvey conducted in January 2021 found a sex-and age-adjusted seroprevalence of 56.1%, reflecting this third wave of transmission and probably indicating a steep increase in the cumulative number of infections. Using the age-adjusted IFR of 0.39%, we estimate the reporting of deaths to be 15.0% (95% CrI 9.3% -34.0%) ( Figure S5 ). Repeating the analysis with an age-adjusted IFR of 0.21%, is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint corresponding to the lower bound of the 95% prediction interval based on age-specific HIC data, 4 increased the reporting rate to 28% (95% CrI 18 -59%). This low rate of reporting is consistent with other cities in India where seroprevalence surveys suggest substantially greater exposure to infection than that predicted based on reported COVID-19 deaths. For example, comparison of seroprevalence during the first half of July 2020 in Mumbai 8 with cumulative deaths at that time, gives an approximate estimate of reporting of 21% (Table S3 ). This high level of under-reporting may reflect both incomplete or delayed reporting of deaths and a failure to report COVID-19 as a suspected or confirmed cause of death, particularly in the absence of a SARS-CoV-2 test result. However, the extent of underreporting is also dependent on the appropriateness of using an age-specific IFR in India derived from HIC data. The age-specific IFR may be lower in India for a number of reasons. First, the prevalence of comorbidities that increase the risk of severe COVID-19 following infection is somewhat lower in India than in the countries that informed the age-specific IFR estimates ( Figure S6 ) 9 . However, correcting the Delhi IFR to account for the lower prevalence of comorbidities only marginally reduces the age-adjusted IFR (by up to 0.02%). Second, a recent study that analysed COVID-19 deaths by age from Mumbai and Karnataka found that the IFR rose less steeply with age than it did in high-income countries 10 . Third, differences in immunity reflecting exposure to a greater number of pathogens (including related coronaviruses) or simply lower frailty among those surviving to older ages in India compared with HICs could theoretically reduce the IFR in older groups, although data supporting these hypotheses are lacking. 11,12 . Using the reconstructed incidence of infections, we also estimated the probability of detecting COVID-19 cases over time by comparing the number of reported cases to the . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint This work has some limitations. First, the transmission model is not structured by age, and therefore, does not account for different mixing patterns between age classes and different attack rates by age. Nonetheless, age-structured models have predicted relatively flat infection attack rates across age for India 13 , consistent with age-stratified seroprevalence estimates 3 . This suggests that any bias in our results from age-specific patterns of mixing and potentially lower attack rates in more susceptible older age groups is likely to be limited. Second, we assume that reporting of deaths has been constant over the study period, but this value might have actually changed over time. Therefore our estimate of reporting represents an average over the study period. Finally, we use estimates of the agespecific IFR from mostly HICs and explore sensitivity to this assumption, including the use of data on comorbidities in India. Further analysis using data from cohort studies or demographic surveillance data in India will help to refine these estimates of the IFR and the exact degree of under-reporting of mortality. At the time of writing (February 2021), the total number of new COVID-19 cases has been declining in India since mid-September 2020. How much of the country's population has already been infected, and whether the herd immunity threshold has been reached are questions currently being debated 14 . Seroprevalence surveys conducted in major cities such as Mumbai, reported seroprevalence rates above 50% in slum areas for the first half of July 8 , is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint suggesting that infection spread very quickly over the first few months in certain pockets, but below 20% in non-slums, showing the epidemic is highly heterogeneous in space. Therefore, the cumulative attack rate in rural areas and smaller cities may be far lower than that reached in major cities. Understanding what has brought the number of cases down in different places in India, and how to interpret the results from serosurveys in terms of the building up of population immunity is key to assess the future dynamics of the epidemic. Although a large proportion of the Indian population may have already been exposed, the is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint Data on the number of SARS-CoV-2 confirmed cases and deaths reported daily in Delhi was available from the 14 th of March through the covid19india.org website. This is a volunteerdriven, crowdsourced initiative that collates data from several sources, including from the Ministry of Health and Family Welfare (MoHFW) and others. Cases and deaths that had occurred before the 14 th of March were reported as cumulative numbers on the first date of the dataset (i.e. 14 th March 2020). As we do not know when these cases and deaths occurred, we did not use the data reported on the 14 th of March for parameter inference. We use data from three serosurveys conducted in Delhi 3 . The dates of sample collection, the number of samples tested, the seropositivity rate found, and the reported estimates of sensitivity and specificity of the assay used in each of the three serosurveys are summarised in Table S1 . We use projections of the population in Delhi for 2021 generated by the National Commission on Population 15 split into age classes of 10 years. To model SARS-CoV-2 transmission we use a Susceptible-Exposed-Infected-Recovered (SEIR) deterministic transmission model ( Figure S7 , equations in the Supplementary Material). We is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint do not stratify the population by age with respect to transmission parameters, and therefore assume random mixing by age such that the epidemic growth is equivalent in all age groups. We do not account for births, or deaths due to causes other than COVID-19, because of the short timeframe for the model. The generation time has been estimated at about 6.5 days, with infectiousness typically beginning in the day before symptoms start 16, 17 . Given an incubation period of about 5.5 days, 18 we therefore assumed a mean duration of the latency (pre-infectious period) of 4.5 days and a mean duration of infectiousness of 2 days to give the correct generation time. We model disease progression and death following infection independently of the transmission process ( Figure S7 ). As the model has been used for other purposes, it also includes hospitalisations, although these are not relevant for the work presented here and do not affect the results. We use an incubation period (i.e. presymptomatic) with mean of 5.5 days, and a peaked distribution modelled by an Erlang distribution with shape parameter 6 as observed. 18 We assume that one third of infections are asymptomatic (although there is high variability in the observed proportion across studies 19-21 and a general increase in the proportion of infected that show symptoms through age 22, 23 ). The proportion of total infections (asymptomatic and symptomatic) leading to hospitalisation and death are tracked separately -i.e. there is overlap between . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted March 26, 2021. ; https://doi.org/10.1101/2021.03.23.21254092 doi: medRxiv preprint compartments for hospitalised individuals and those that will die (fatal infections). The proportion of infections leading to hospitalisation (with critical or non-critical care need respectively) are age-adjusted with the demographics from Delhi and age-stratified estimates from 6 based on data from China. Similarly, the proportion of infections leading to death (i.e. the age-adjusted IFR) is based on estimates of age-stratified IFR from 4 applied to the population of Delhi. The average time from symptom onset to hospitalisation is set to 5.8 days, consistent with observations in China 24 . We assume a mean duration of hospital stay of 9.8 days if no critical care and 9.8 days if critical care required, followed by 3.3 days to recover in non-critical care (stepdown), based on early, unpublished UK estimates. Note these estimates do not affect our results, which are not based on hospitalisations. The average time from symptom onset to death was around 16 days 6 . We therefore assume a mean delay between the time of hospitalisation and death of 10 days. These values may be different for India, but no data is currently available. We fit the transmission model to both the seroprevalence data and the daily incidence of is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted March 26, 2021. where the mean is × ℎ ( ) and the variance is × ℎ ( ) + ( × ℎ ( )) $ ( × ℎ ( )) % ⁄ . We is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint with the overdispersion parameter fixed to = 1/0.7, due to the small number of observations available to accurately estimate it. We allow the reproduction number, R, to change at 5 different time points corresponding to the time of changes in interventions (Table S2) . We denote 6 the basic reproduction number during the first period (i.e. before any changes), and ' the reproduction number after the i-th change and during the (i+1)-th (i in 1,…,5) period. We parameterise it as ' = We estimate the initial value of the reproduction number ( 6 ) and the subsequent changes at each time point ( 1 , … , 7 ), the initial number of infected ( (0) + (0)), the reporting ( ) and overdispersion of deaths ( ). We assume the starting time for the simulations, 6 , to be the 19 th of February 2020 (i.e. 28 days before the first ten cases were reported) and estimate the number of infected individuals at that time point ( (0) + (0)). The first change on the reproduction number, corresponding to the start of the lockdown on the 25 th of March (and modelled through the parameter 1 ), could not be estimated, because the number of deaths at that time did not allow to infer a change in transmission (no deaths reported between the 15 th and the 28 th of March). We therefore assumed 1 = 0, and the subsequent change on the reproduction number ( $ ) was assumed to occur on the 4 th of May, when the first relaxations were introduced. Therefore, the estimate of the . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint Concordat agreement and is also part of the EDCTP2 programme supported by the European Union; and acknowledge funding by Community Jameel. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted March 26, 2021. ; https://doi.org/10.1101/2021.03.23.21254092 doi: medRxiv preprint India's epidemic adviser fears coronavirus crisis will worsen Is India missing COVID-19 deaths? The prevalence and trends of SARS-CoV-2 infection in Delhi: A population-based seroepidemiological study COVID-19 Infection Fatality Ratio: Estimates from Seroprevalence Age-specific mortality and immunity patterns of SARS-CoV-2 Estimates of the severity of coronavirus disease 2019: a model-based analysis Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications Seroprevalence of SARS-CoV-2 in slums versus non-slums in Mumbai Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study Representative Estimates of COVID-19 Infection Fatality Rates from Three Locations in India The mortality due to COVID-19 in different nations is associated with the demographic character of nations and the prevalence of autoimmunity COVID 19 mortality: Probable role of microbiome to explain disparity The impact of COVID-19 and strategies for mitigation and suppression in low-and middle-income countries India's COVID-19 cases have declined rapidly -but herd immunity is still far away, scientists say Census of India 2011. Population projections for India and states 2011-2036: report of the technical group on population projections Serial interval of novel coronavirus (COVID-19) infections Epidemiology and transmission of COVID-19 in Shenzhen China: analysis of 391 cases and 1,286 of their close contacts The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application The Proportion of SARS-CoV-2 Infections That Are Asymptomatic : A Systematic Review A Rapid Reviewand Meta-Analysisof the Asymptomatic Proportion of PCR-Confirmed SARS-CoV-2 Infections in Community Settings Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: A living systematic review and metaanalysis Age-dependent effects in the transmission and control of COVID-19 epidemics Probability of symptomsand critical disease after SARS-CoV-2 infection Symptom progression of COVID-19 Revealing the extent of the COVID-19 pandemic in Kenya based on serological and PCR-test data How generation intervals shape the relationship between growth rates and reproductive numbers Estimating the burden of SARS-CoV-2 in France R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing